Brokerages Set Celestica, Inc. (NYSE:CLS) PT at $427.42

Celestica, Inc. (NYSE:CLS) (TSE:CLS) has been given an average recommendation of “Buy” by the twenty-two research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, eighteen have given a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $427.4211.

Several equities research analysts have recently issued reports on the stock. UBS Group raised their price objective on shares of Celestica from $355.00 to $400.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Royal Bank Of Canada increased their price target on shares of Celestica from $400.00 to $440.00 and gave the company an “outperform” rating in a report on Wednesday, April 29th. Stifel Nicolaus set a $445.00 price target on shares of Celestica in a research report on Tuesday, April 28th. Zacks Research upgraded shares of Celestica from a “hold” rating to a “strong-buy” rating in a report on Friday, June 26th. Finally, Weiss Ratings lowered shares of Celestica from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday, July 16th.

Key Celestica News

Here are the key news stories impacting Celestica this week:

• Positive Sentiment: Analyst commentary remains constructive ahead of earnings, citing strong demand in AI infrastructure, cloud, and healthcare, along with rising estimates and the potential for another earnings beat. Celestica to Release Q2 Earnings: How to Approach the Stock Now?
• Positive Sentiment: Some bullish research says Celestica has improved long-term revenue visibility, with AI infrastructure tailwinds and resolved component shortages supporting guidance and future growth. Celestica: The Market Just Started To Agree, And Q2 Isn’t Posed Yet
• Neutral Sentiment: Recent articles focus on valuation, with some saying the stock may still screen as inexpensive on earnings expectations while others argue it has already run far enough that upside is less certain. Celestica (TSX:CLS) Stock Looks Above Fair Value Despite Its Huge Run
• Neutral Sentiment: Market watchers are also debating whether the upcoming quarter can support the stock’s prior surge, with one preview framing Q2 as a key test for the AI hardware trade. Celestica Q2 Preview: The 1.6T Supercycle Meets The Overbuild Dilemma
• Negative Sentiment: The stock has been under pressure recently, with traders noting a deeper pullback than the broader market and a move into bear-market territory after a sharp run-up. Celestica (CLS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
• Negative Sentiment: Another note said Celestica’s shares have dropped sharply from this year’s highs, reflecting concern that a lot of the AI growth story may already be priced in. Celestica stock tumbles ahead of earnings: rebound or more pain?

Insider Buying and Selling

In related news, CEO Robert Mionis sold 18,176 shares of the business’s stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of $385.17, for a total transaction of $7,000,849.92. Following the transaction, the chief executive officer directly owned 60,384 shares in the company, valued at $23,258,105.28. The trade was a 23.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Michael Max Wilson sold 4,168 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $333.31, for a total value of $1,389,236.08. Following the completion of the transaction, the director directly owned 24,718 shares of the company’s stock, valued at approximately $8,238,756.58. This trade represents a 14.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 161,168 shares of company stock valued at $63,190,485 over the last three months. 1.10% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Bay Rivers Group lifted its position in Celestica by 0.3% in the second quarter. Bay Rivers Group now owns 14,922 shares of the technology company’s stock worth $5,444,000 after purchasing an additional 47 shares during the period. Arista Wealth Management LLC increased its holdings in Celestica by 31.1% in the 2nd quarter. Arista Wealth Management LLC now owns 4,714 shares of the technology company’s stock valued at $1,720,000 after buying an additional 1,117 shares during the period. Tactive Advisors LLC bought a new stake in Celestica in the 2nd quarter valued at $509,000. Hennion & Walsh Asset Management Inc. raised its stake in shares of Celestica by 47.5% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 3,874 shares of the technology company’s stock valued at $1,413,000 after buying an additional 1,248 shares in the last quarter. Finally, Sunburst Financial Group LLC raised its stake in shares of Celestica by 13.7% in the 2nd quarter. Sunburst Financial Group LLC now owns 830 shares of the technology company’s stock valued at $303,000 after buying an additional 100 shares in the last quarter. 67.38% of the stock is currently owned by institutional investors and hedge funds.

Celestica Price Performance

Shares of NYSE:CLS opened at $335.45 on Thursday. The company has a market cap of $38.57 billion, a price-to-earnings ratio of 40.56, a PEG ratio of 0.78 and a beta of 2.05. The business has a 50 day moving average price of $364.08 and a 200 day moving average price of $332.18. The company has a quick ratio of 0.73, a current ratio of 1.26 and a debt-to-equity ratio of 0.36. Celestica has a twelve month low of $158.15 and a twelve month high of $474.02.

Celestica (NYSE:CLS) (TSE:CLS) last issued its quarterly earnings results on Monday, April 27th. The technology company reported $2.16 EPS for the quarter, topping the consensus estimate of $2.08 by $0.08. Celestica had a return on equity of 36.91% and a net margin of 6.95%.The company had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.97 billion. During the same period in the previous year, the business posted $1.20 EPS. The company’s revenue for the quarter was up 52.8% on a year-over-year basis. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. Research analysts predict that Celestica will post 9.57 earnings per share for the current year.

Celestica Company Profile

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.